Evidence that phospholipase C is involved in the antitumour action of NSC768313, a new thieno[2,3-b]pyridine derivative.

Reynisson, Jóhannes; Jaiswal, Jagdish K; Barker, David; D'mello, Stacey A N; Denny, William A; Baguley, Bruce C; Leung, Euphemia Y

Reynisson, Jóhannes; Jaiswal, Jagdish K; Barker, David; D'mello, Stacey A N; Denny, William A; Baguley, Bruce C; Leung, Euphemia Y.

Afiliación

Reynisson J; School of Chemical Sciences, University of Auckland, Auckland, New Zealand.
Jaiswal JK; Auckland Cancer Society Research Centre, University of Auckland, Private Bag 92019, Auckland, 1142 New Zealand.
Barker D; School of Chemical Sciences, University of Auckland, Auckland, New Zealand.
D'mello SA; Auckland Cancer Society Research Centre, University of Auckland, Private Bag 92019, Auckland, 1142 New Zealand ; Molecular Medicine and Pathology Department, University of Auckland, Private Bag 92019, Auckland, 1142 New Zealand.
Denny WA; Auckland Cancer Society Research Centre, University of Auckland, Private Bag 92019, Auckland, 1142 New Zealand.
Baguley BC; Auckland Cancer Society Research Centre, University of Auckland, Private Bag 92019, Auckland, 1142 New Zealand.
Leung EY; Auckland Cancer Society Research Centre, University of Auckland, Private Bag 92019, Auckland, 1142 New Zealand ; Molecular Medicine and Pathology Department, University of Auckland, Private Bag 92019, Auckland, 1142 New Zealand.

Cancer Cell Int ; 16: 18, 2016.

Article en En | MEDLINE | ID: mdl-26966420

Palabras clave

3-b]pyridine; Cancer; Cell cycle arrest; Membrane blebbing; Paclitaxel; Phospholipase C; Synergy; Thieno[2

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Cancer Cell Int Año: 2016 Tipo del documento: Article País de afiliación: Nueva Zelanda

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google